ABSTRACT
OBJECTIVE: To evaluate the effectiveness of surgical treatment of patients with malignancies of lungs, pleura and chest wall in early and long-term follow-up period in anti-tuberculosis hospital. MATERIAL AND METHODS: There were 2139 patients between 2016 and 2020. Chest tumors were diagnosed in 290 (13.6%) patients and 210 (94.2%) ones underwent surgery. RESULTS: Surgical interventions are rare in patients with lung cancer and active tuberculosis (0.7%, n=15). Lobectomies prevailed (73.3%). All sublobar resections were performed in elderly patients with severe comorbidities and low functional reserves. Postoperative complications occurred in 9% of cases. Overall 3-year survival rate was 84.8%, overall 5-year survival rate - 70.8%. Overall survival of patients with lung cancer and tuberculosis does not depend on activity of specific process. CONCLUSION: The TRA test used in differential diagnostics of tuberculosis and lung cancer has a mediating value. Lung cancer surgery in patients with active tuberculosis has no negative effect on effectiveness of tuberculosis treatment. Surgical treatment of malignancies in anti-tuberculosis hospital can be performed in accordance with standards of specialized medical care in oncology.
Subject(s)
Lung Neoplasms , Pneumonectomy , Humans , Aged , Treatment Outcome , Neoplasm Staging , Pneumonectomy/adverse effects , Lung Neoplasms/diagnosis , Lung Neoplasms/surgery , Hospitals , Retrospective StudiesABSTRACT
64 patients with lung tuberculosis were operated on after chemotherapy course using regimens I and III. 69 patients were operated on after the treatment by DOTS/PLUS protocol. The obtained operative material was bacteriologically tested. Bacterial growth in samples of patients treated with DOTS/PLUS protocol caused by multydrug resistance of mycobacteria. The noncoinsidence of the drug resistance spectrum in sputum and resected samples was registered in 33% of patients treated by DOTS/ PLUS protocol and 25% of patients, treated by using regimens I and III.
